Radius Health (RDUS) Announces FDA Approval for TYMLOS for Treatment of Postmenopausal Women with Osteoporosis

April 28, 2017 11:04 AM
Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing innovative therapeutics in the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Management Comments

Next Articles